Navigation Links
SDCRM Receives Highest Score in Three of Four Categories from CIRM on Part I of Major Facilities Grant Application

SAN DIEGO, Jan. 18 /PRNewswire/ -- The San Diego Consortium for Regenerative Medicine (SDCRM) today announced that it has received the highest score in three of four categories from the California Institute of Regenerative Medicine (CIRM) on Part I of the Major Facilities Grant Application.

SDCRM's application, which was submitted last October, earned scores of 99 for basic research and discovery, 95 for preclinical research, 94 for preclinical development and 93 for use and contribution. Each of the four areas was evaluated on a scale of one to 100. Scores were approved by the Independent Citizens' Oversight Committee (ICOC) on Jan. 16. The Part I application contained information about SDCRM's scientific program, including the consortium's focus on the areas of neuroscience, hematopoiesis, heart disease, ophthalmic diseases and diabetes, among others.

California Institute for Regenerative Medicine

Summaries of Scientific Review Reports (Grants Working Group)

Major Facilities Grant RFA-07-03







Research Use &

Translat- & contribu-

Application Application Basic ional Develop- tion

# Organization Type Research Research ment Score

FA1-00607-1 SDCRM Institute 99 95 94 93

FA1-00609-1 Stanford

University Institute 96 95 91 95

FA1-00612-1 UC, Irvine Institute 94 94 90 92

FA1-00613-1 UCLA Institute 90 81 89 90

FA1-00616-1 UC, Santa

Barbara Institute 90 81 89 70

FA1-00617-1 UC, Santa Cruz Institute 90 81 89 84

FA1-00618-1 UC, San

Francisco Institute 90 81 89 92

FA1-00619-1 USC Institute 90 81 89 80

FA1-00611-1 UC, Davis Institute 85 90 83 88

FA1-00600-1 The Buck

Institute for

Age Research Center 81 85 83

FA1-00610-1 UC, Berkeley Center 80 75 80

FA1-00614-1 UC, Merced Program 72 71

"We are pleased that CIRM and the ICOC recognize the advantages of this type of collaboration and the need for a centralized location to conduct and translate research," said Edward Holmes, M.D., SDCRM's President and CEO. "This facility will enable the outstanding investigators who have and will join SDCRM to pursue the type of stem cell research that leads to breakthroughs in our understanding of human disease and where results with the greatest potential to help patients are translated into new therapies."

SDCRM will submit Part II of the Major Facility Grant Application, which contains technical information about the facility and how SDCRM's scientific program aligns with CIRM's objectives, in February. ICOC review and ultimate funding decisions will take place in April of this year.


Formed in 2005, the San Diego Consortium for Regenerative Medicine (SDCRM) is a nonprofit organization that marshals the intellectual resources of four world-leaders in life sciences research, including the Burnham Institute for Medical Research, the Salk Institute for Biological Studies, The Scripps Research Institute and the University of California, San Diego. In addition to the collective strength of its members, SDCRM's research program goals are to invent research tools and technologies to hasten the pace of stem cell research progress and to discover and develop diagnostics, therapies and cures to relieve human suffering from chronic disease and injury.

Contact: Tracey Milani or David Schull

Russo Partners


SOURCE The San Diego Consortium for Regenerative Medicine
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
2. Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer
3. Arpida Receives Green Light From US FDA for Phase II Efficacy Trial With Oral Iclaprim
4. Genta Receives Notice of Non-Compliance With NASDAQ Rule
5. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
6. Harborview Medical Center in Seattle Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service
7. EaglePicher Technologies Receives Battery Power Products and Technologys First Annual Innova Award
8. Aida Receives Chinese Government Innovation Award
9. Three Palm Software Receives FDA 510(k) Clearance for Its WorkstationOne(TM) Breast Imaging Workstation
10. Genta Receives NASDAQ Non-Compliance Notice
11. Tapestry Receives Notice Regarding Minimum Bid Price Rule
Post Your Comments:
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free ... and will showcase its product’s latest features from June 26 to June 30, ... poster on Disrupting Clinical Trials in The Cloud during the conference. DIA ...
Breaking Biology Technology:
(Date:6/7/2016)... 7, 2016  Syngrafii Inc. and San Antonio ... that includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" ... collaboration will result in greater convenience for SACU ... while maintaining existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/24/2016)... May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology ... LCD display is the latest premium product recently added to the range of products ... ... ... 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):